⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
TGTX News
TG Therapeutics, Inc.
TG Therapeutics to Host Conference Call on First Quarter 2026 Financial Results and Business Update
globenewswire.com
TGTX
Chronic Obstructive Pulmonary Disease Clinical Trial Landscape Expands: Over 65 Companies Advancing Next-Generation Therapies | DelveInsight
globenewswire.com
REGN
SNY
AZN
AVTX
BHVN
GSK
RPRX
PLUR
MESO
EDIT
CRSP
NTLA
ALNY
MRNA
PFE
NVS
TEVA
LPCN
GILD
AMGN
BMY
ABBV
LLY
JNJ
BIIB
XRAY
HOLX
SYK
ISRG
COO
MASI
CYTK
ATRC
RDNT
GH
EXAS
CLDX
ACRS
ADPT
ALKS
APLS
ASMB
CHKP
CODX
CRBU
CTAS
DAKT
DBI
DDS
DELL
DLTR
DOCU
DOX
DXCM
EA
EBAY
ELAN
EPAM
ERIC
ETSY
EXPD
F
FAST
FCX
FIS
FISV
FMC
FOX
FRPT
FTNT
G
GLPG
GM
GNRC
GOOG
GOOGL
GRMN
GWW
HCA
HD
HII
HLT
HON
HPQ
HRB
HRL
HSIC
HST
HTZ
HWM
IBM
ICE
ICLR
IDXX
ILMN
INCY
INGN
INTC
INTU
IPGP
IQV
IRTC
ITW
IVZ
JBL
JCI
JEF
JPM
KDP
KHC
KIM
KMB
KMI
KMX
KO
KODK
L
LBTYA
LBRDK
LIN
LKQ
LNT
LOPE
LOW
LRCX
LULU
LUV
LYFT
M
MA
MAR
MAS
MAT
MDLZ
MELI
MGM
MCHP
MICC
MITK
MKC
MLCO
MNST
MO
MRVL
MS
MSFT
MSI
MTCH
MTN
MU
NCLH
NDAQ
NDSN
NEE
NEM
NFLX
NI
NKE
NOC
NOV
NOW
NRG
NTAP
NTES
NTRS
NUE
NVDA
NWSA
NXPI
O
ODFL
OFG
OGN
OKE
OMC
OMER
ON
ORCL
ORLY
OSBC
OTIS
OVV
P
PANW
PAYX
PCAR
PCG
PDD
PEP
PERI
PETS
PFG
PGR
PG
PH
PHG
PHI
PHM
PI
PII
PKX
PLD
PLUG
PLX
PM
PNC
PPC
PPG
PPL
PRGO
PRGS
PRU
PSA
PSMT
PTC
PTEN
PTON
PYPL
QCOM
QGEN
QLYS
QRVO
R
RBLX
RCL
REI
RELX
RF
RGEN
RHI
RIVN
RL
RLX
RMD
RNG
ROKU
ROST
RRC
RRGB
RS
RSG
RTX
RUN
RVSN
S
SABR
SAN
SAVA
SBAC
SBUX
SCHW
SD
SEE
SEIC
SEM
SIRI
SITE
SJM
SLB
SLGN
SLP
SM
SMCI
SMLR
SNA
SNDR
SNOW
SNPS
SO
SONY
SPG
SPGI
SPOT
SQM
SSNC
ST
STAG
STLD
STNG
STOK
STX
SUN
SWKS
SXI
SYPR
T
TAL
TCOM
TD
TDG
TDOC
TECK
TEF
TEN
TER
TFX
TGT
TGTX
THC
THO
TIGR
TJX
TLRY
TMO
TM
TNDM
TNET
TOL
TOPS
TPH
TPL
TR
TRC
TRIP
TRMB
TRN
TROX
TRP
TRT
TS
TSLA
TSM
TSN
TT
TTC
TTEC
TTWO
TU
TV
TW
TWLO
TX
TXN
TXRH
TXT
TYL
U
UAL
UDR
UEC
UHS
UL
ULTA
UMC
UMH
UNH
UNIT
UNM
UPS
URBN
USFD
USNA
USPH
UTHR
V
VRSN
VRTX
VRSK
VTR
VTRS
W
WAB
WDC
WEC
WELL
WEN
WFC
WGO
WHR
WMB
WMS
WMT
WOOF
WPC
WPP
WSC
WSM
WST
WTI
WTW
WU
WVE
WY
WYNN
XCUR
XENE
XOM
XPEV
XPO
XRX
XTLB
XXII
XYL
YETI
YMM
YUM
Z
ZBH
ZBRA
ZION
ZNTL
ZUMZ
ZYME
TG Therapeutics Announces Data Presentations for BRIUMVI in Multiple Sclerosis at the American Academy of Neurology 2026 Annual Meeting
globenewswire.com
TGTX
Multiple Sclerosis Market Competitive Landscape Report 2026: Comprehensive Insights on Over 60 Companies and 75 Drugs by Product Type, Development Stage, Administration Route, and Molecule Type
globenewswire.com
SNY
IMUX
TLSA
BIIB
BMY
TGTX
Form 8-K
sec.gov
TGTX
TG Therapeutics Secures an Additional $500 Million in Non-Dilutive Capital from Blue Owl and Expands Share Repurchase Program to $300 Million
globenewswire.com
TGTX
CD19 Inhibitors Market to Witness Significant Expansion During the Forecast Period (2025-2034) as Autoimmune and Oncology Pipelines Accelerate | DelveInsight
prnewswire.com
GILD
INCY
BIIB
NVS
AMGN
JNJ
ABBV
BMY
AZN
MRK
PFE
TGTX
XNCR
CABA
IMUX
ZNTL
GLPG
CLNN
AUTL
Data Published in Neurology and Therapy Demonstrate Significant Reductions in Relapse and MRI Activity with BRIUMVI® in People with Highly Active Relapsing Multiple Sclerosis
globenewswire.com
TGTX
TG Therapeutics Announces Schedule of Data Presentations for BRIUMVI® (ublituximab) in Multiple Sclerosis at the American Academy of Neurology 2026 Annual Meeting
globenewswire.com
TGTX
Tangram Therapeutics annonce l’administration de la première dose à un participant dans le cadre de l’essai RESTORE-MASH de phase I/II portant sur le TGM-312, un nouveau médicament expérimental à base d’ARNi
globenewswire.com
TGTX